Treatment of relapsed and refractory multiple myeloma in the era of novel agents-Reference-Cited by-同舟云学术

Treatment of relapsed and refractory multiple myeloma in the era of novel agents

Published:2011-06 Issue:4 Volume:37 Page:266-283
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

van de Donk Niels W.C.J.,Lokhorst Henk M.,Dimopoulos Meletios,Cavo Michele,Morgan Gareth,Einsele Hermann,Kropff Martin,Schey Steve,Avet-Loiseau Hervé,Ludwig Heinz,Goldschmidt Hartmut,Sonneveld Pieter,Johnsen Hans E.,Bladé Joan,San-Miguel Jesús F.,Palumbo Antonio

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Reference225 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

2. International uniform response criteria for multiple myeloma;Durie;Leukemia,2006

3. Clinically relevant end points and new drug approvals for myeloma;Anderson;Leukemia,2008

4. The International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol 2003;121(5):749–57.

5. Antitumor activity of thalidomide in refractory multiple myeloma;Singhal;N Engl J Med,1999

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Immune Cells and Immunotherapy in Multiple Myeloma;Life;2024-04-01

2. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment;Leukemia Research;2021-06

3. Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing;Nature Medicine;2021-02-22

4. Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma;Cancers;2020-01-28

5. CD38 Antibodies in Multiple Myeloma: Mechanisms of Action and Modes of Resistance;Frontiers in Immunology;2018-09-20